Related Experiment Video

Updated: May 20, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Immunological HCV-associated thrombocytopenia: short review

Dimitrios Dimitroulis1, Serena Valsami, Paraskevas Stamopoulos

  • 1Second Department of Propaedeutic Surgery, Laiko Hospital, Athens University Medical School, Sakellariou 4 Street, Alimos, 17455 Athens, Greece. dimitroulisdimitrios@yahoo.com

Clinical & Developmental Immunology
|July 26, 2012
PubMed

Insights

Hepatitis C virus (HCV) infection can cause autoimmune thrombocytopenia, a condition with unique features. This paper reviews its epidemiology, pathogenesis, clinical presentation, and treatment options.

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Hepatitis C virus (HCV) affects 3% of the global population, causing liver damage and hepatocellular carcinoma.
  • HCV infection is a leading cause for liver transplantation in the USA.
  • HCV can trigger immunological conditions like glomerulonephritis, pulmonary fibrosis, and thrombocytopenia.

Purpose of the Study:

  • To estimate the epidemiological characteristics of HCV-related autoimmune thrombocytopenia.
  • To investigate the pathogenesis and clinical manifestations of this condition.
  • To propose evidence-based treatment strategies for HCV-related autoimmune thrombocytopenia.

Main Methods:

  • Literature review of epidemiological data.
  • Analysis of pathogenetic mechanisms.
  • Review of clinical presentations and treatment outcomes.

Main Results:

  • HCV-related autoimmune thrombocytopenia exhibits distinct pathogenetic and clinical features compared to non-HCV-associated thrombocytopenia.
  • Severity and frequency of symptoms vary significantly in HCV-infected patients.
  • Specific treatment approaches are being explored based on disease characteristics.

Conclusions:

  • HCV-related autoimmune thrombocytopenia is a significant extrahepatic manifestation of HCV infection.
  • Understanding its unique aspects is crucial for effective management.
  • Further research into targeted therapies is warranted.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...